Table 2.
Weighted Linear Mixed-Effect Models of the Association Between Reproductive Hormones and C-reactive Protein in the BioCycle Study, Buffalo, New York, 2005–2007
| Hormones and Model | β (SE) | % Change Per 10-Fold Increase in Exposure | 95% CI | P Value |
| Estradiol (all phases) | ||||
| 1a | −0.10 (0.01) | −20.57 | −25.53, −15.28 | <0.001 |
| 2b | −0.12 (0.01) | −24.32 | −29.04, −19.28 | <0.001 |
| Progesterone (luteal phase) | ||||
| 1 | 0.08 (0.02) | 19.95 | 9.40, 31.52 | <0.001 |
| 2 | 0.08 (0.02) | 19.40 | 8.39, 31.52 | <0.001 |
| LH (ovulation) | ||||
| 1 | −0.02 (0.02) | −3.84 | −11.49, 4.71 | 0.37 |
| 2 | −0.01 (0.02) | −2.73 | −11.28, 6.66 | 0.57 |
| FSH (all phases) | ||||
| 1 | −0.05 (0.03) | −3.62 | −19.46, −2.95 | 0.01 |
| 2 | −0.02 (0.02) | −4.06 | −12.70, 5.68 | 0.41 |
Abbreviations: β, effect estimate; CI, confidence interval; FSH, follicle-stimulating hormone; LH, luteinizing hormone; SE, standard error.
a
Unadjusted.
b
Weighted for age (continuous), race (white, black, other), body mass index (continuous), total cholesterol (continuous, log transformed), and other reproductive hormones (continuous, log transformed).